Moreover, significantly elevated CSNK1D levels have been observed in various cancer types, including breast carcinoma [6, 7], hepatocellular carcinoma [8, 9], prostate cancer [10], glioblastoma [11], multiple myeloma [12], and bladder cancer [13]. This evidence concerns the gene CSNK1D and plasma cell myeloma.